MedPath

Effect of Gabapentin on Pain of the Second Cataract Surgery

Phase 4
Conditions
Hyperalgesia
Interventions
Drug: placebo
Registration Number
NCT02127853
Lead Sponsor
Seoul National University Hospital
Brief Summary

Gabapentin pretreatment may reduce hyperalgesia occurring at the second surgery in serial, bilateral cataract surgery.

Detailed Description

Hyperalgesia occurring at the second operation in bilateral eye surgery is well known, and mechanism of central sensitization might be involved. Gabapentin is known to lower the effect of central sensitization, and its effect on acute postoperative pain has been reported. Therefore, pretreatment of gabapentin after first operation may reduce the pain at second operation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patient of ASA(American Cociety of Anesthesiology) class I, II, III between age 20 to 80, scheduled for serial bilateral cataract surgery(1 weel interval)
Exclusion Criteria
  • refuse to participate
  • BMI<16 or BMI >30
  • severe cardiovascular, pulmonary, renal disease
  • alcohol or drug abuse
  • currently taking CNS(central nervous system) inhibitory drugs
  • taking antiacids
  • depressive disorder pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placeboplaceboplacebo drug pretreatment
Gabapentingabapentingabapentin pretreatment
Primary Outcome Measures
NameTimeMethod
proportion of subjects who answer that "pain was greater" in the second eye surgeryIntra operative (pain while fluid injection to anterior chamber)
Secondary Outcome Measures
NameTimeMethod
perioperative painend of surgery, post-op 1hr at PACU, at out-patient ward, post-op 1 day

evaluation of overall perioperative pain

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath